Sarah Carmody

Plus aucun poste en cours

Health Technology

Profil

Sarah Carmody worked as an Executive Director-Investor & Communications at Mersana Therapeutics, Inc. from 2018 to 2022.
She also served as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Manager-Corporate Communications at Verenium Corp.
from 2010 to 2013.
Additionally, she held the position of VP-Investor Relations & Corporate Communications at Vigil Neuroscience, Inc.

Anciens postes connus de Sarah Carmody

Sociétés	Poste	Fin
VIGIL NEUROSCIENCE, INC.	Investor Relations Contact	01/06/2023
MERSANA THERAPEUTICS	Investor Relations Contact	01/01/2022
VERENIUM CORP	Investor Relations Contact	01/12/2013
MOMENTA PHARMACEUTICALS, INC.	Investor Relations Contact	-

Voir l'expérience en détail de Sarah Carmody

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sarah Carmody

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases	Health Technology
Mersana Therapeutics, Inc. Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications	Health Technology
Verenium Corp. Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks	Health Technology
Vigil Neuroscience, Inc. Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases	Health Technology